Aberrant expression of KPNA2 is closely associated with the occurrence and progression of various cancers, especially gallbladder cancer, colorectal cancer and breast cancer, where its pro‐tumorigenic properties have been widely confirmed [21, 22, 23]. Here, KPNA2 is linked to gallbladder cancer.